-
1
-
-
58649100056
-
Inflammation and cancer: IL-6 and STAT3 complete the link
-
Bromberg J, Wang TC,. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 2009; 15: 79-80.
-
(2009)
Cancer Cell
, vol.15
, pp. 79-80
-
-
Bromberg, J.1
Wang, T.C.2
-
2
-
-
77149147422
-
Interleukin-6: A therapeutic Jekyll and Hyde in gastrointestinal and hepatic diseases
-
Danese S, Gao B,. Interleukin-6: A therapeutic Jekyll and Hyde in gastrointestinal and hepatic diseases. Gut 2010; 59: 149-51.
-
(2010)
Gut
, vol.59
, pp. 149-151
-
-
Danese, S.1
Gao, B.2
-
3
-
-
0030940098
-
Interleukin-6: Structure-function relationships
-
Simpson RJ, Hammacher A, Smith DK, Matthews JM, Ward LD,. Interleukin-6: Structure-function relationships. Protein Sci. 1997; 6: 929-55. (Pubitemid 27194135)
-
(1997)
Protein Science
, vol.6
, Issue.5
, pp. 929-955
-
-
Simpson, R.J.1
Hammacher, A.2
Smith, D.K.3
Matthews, J.M.4
Ward, L.D.5
-
4
-
-
79955650634
-
The pro- and anti-inflammatory properties of the cytokine interleukin-6
-
Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S,. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 2011; 1813: 878-88.
-
(2011)
Biochim. Biophys. Acta
, vol.1813
, pp. 878-888
-
-
Scheller, J.1
Chalaris, A.2
Schmidt-Arras, D.3
Rose-John, S.4
-
5
-
-
0030731621
-
NIDDM as a disease of the innate immune system: Association of acute- phase reactants and interleukin-6 with metabolic syndrome X
-
DOI 10.1007/s001250050822
-
Pickup JC, Mattock MB, Chusney GD, Burt D,. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286-92. (Pubitemid 27469668)
-
(1997)
Diabetologia
, vol.40
, Issue.11
, pp. 1286-1292
-
-
Pickup, J.C.1
Mattock, M.B.2
Chusney, G.D.3
Burt, D.4
-
6
-
-
65549113825
-
Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index
-
Ruge T, Lockton JA, Renstrom F, et al,. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index. Metabolism 2009; 58: 860-66.
-
(2009)
Metabolism
, vol.58
, pp. 860-866
-
-
Ruge, T.1
Lockton, J.A.2
Renstrom, F.3
-
7
-
-
0035023128
-
Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
-
Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G,. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2001; 280: E745-51.
-
(2001)
Am. J. Physiol. Endocrinol. Metab.
, vol.280
-
-
Kern, P.A.1
Ranganathan, S.2
Li, C.3
Wood, L.4
Ranganathan, G.5
-
8
-
-
70350704815
-
Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: Possible pathogenic role in diabetic nephropathy
-
Min D, Lyons JG, Bonner J, Twigg SM, Yue DK, McLennan SV,. Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: Possible pathogenic role in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2009; 297: F1229-37.
-
(2009)
Am. J. Physiol. Renal Physiol.
, vol.297
-
-
Min, D.1
Lyons, J.G.2
Bonner, J.3
Twigg, S.M.4
Yue, D.K.5
McLennan, S.V.6
-
9
-
-
0031066981
-
Circulating Serum Lectins of Patients with IgA Nephropathy Stimulate IL-6 Release from Mesangial Cells
-
Libetta C, Rampino T, Palumbo G, Esposito C, Dal Canton A,. Circulating serum lectins of patients with IgA nephropathy stimulate IL-6 release from mesangial cells. J. Am. Soc. Nephrol. 1997; 8: 208-13. (Pubitemid 127455875)
-
(1997)
Journal of the American Society of Nephrology
, vol.8
, Issue.2
, pp. 208-213
-
-
Libetta, C.1
Rampino, T.2
Palumbo, G.3
Esposito, C.4
Dal Canton, A.5
-
10
-
-
79952040900
-
Calcitriol counteracts endothelial cell pro-inflammatory processes in a chronic kidney disease-like environment
-
Talmor-Barkan Y, Bernheim J, Green J, Benchetrit S, Rashid G,. Calcitriol counteracts endothelial cell pro-inflammatory processes in a chronic kidney disease-like environment. J. Steroid Biochem. Mol. Biol. 2011; 124: 19-24.
-
(2011)
J. Steroid Biochem. Mol. Biol.
, vol.124
, pp. 19-24
-
-
Talmor-Barkan, Y.1
Bernheim, J.2
Green, J.3
Benchetrit, S.4
Rashid, G.5
-
11
-
-
16844377774
-
Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling
-
Zhang XL, Topley N, Ito T, Phillips A,. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. J. Biol. Chem. 2005; 280: 12239-45.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 12239-12245
-
-
Zhang, X.L.1
Topley, N.2
Ito, T.3
Phillips, A.4
-
12
-
-
0025801687
-
Elevated circulating levels of interleukin-6 in patients with chronic renal failure
-
Herbelin A, Urena P, Nguyen AT, Zingraff J, Descamps-Latscha B,. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int. 1991; 39: 954-60.
-
(1991)
Kidney Int.
, vol.39
, pp. 954-960
-
-
Herbelin, A.1
Urena, P.2
Nguyen, A.T.3
Zingraff, J.4
Descamps-Latscha, B.5
-
13
-
-
0036712017
-
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment
-
Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P,. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol. Dial. Transplant. 2002; 17: 1684-8. (Pubitemid 35012175)
-
(2002)
Nephrology Dialysis Transplantation
, vol.17
, Issue.9
, pp. 1684-1688
-
-
Pecoits-Filho, R.1
Barany, P.2
Lindholm, B.3
Heimburger, O.4
Stenvinkel, P.5
-
14
-
-
29244475380
-
Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD
-
DOI 10.1053/j.ajkd.2005.09.014, PII S0272638605014447
-
Honda H, Qureshi AR, Heimburger O, et al,. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am. J. Kidney Dis. 2006; 47: 139-48. (Pubitemid 41828276)
-
(2006)
American Journal of Kidney Diseases
, vol.47
, Issue.1
, pp. 139-148
-
-
Honda, H.1
Qureshi, A.R.2
Heimburger, O.3
Barany, P.4
Wang, K.5
Pecoits-Filho, R.6
Stenvinkel, P.7
Lindholm, B.8
-
15
-
-
77949540909
-
Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease
-
Barreto DV, Barreto FC, Liabeuf S, et al,. Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int. 2009; 77: 550-56.
-
(2009)
Kidney Int.
, vol.77
, pp. 550-556
-
-
Barreto, D.V.1
Barreto, F.C.2
Liabeuf, S.3
-
16
-
-
73949092319
-
The absence of interleukin-6 enhanced arsenite-induced renal injury by promoting autophagy of tubular epithelial cells with aberrant extracellular signal-regulated kinase activation
-
Kimura A, Ishida Y, Wada T, et al,. The absence of interleukin-6 enhanced arsenite-induced renal injury by promoting autophagy of tubular epithelial cells with aberrant extracellular signal-regulated kinase activation. Am. J. Pathol. 2010; 176: 40-50.
-
(2010)
Am. J. Pathol.
, vol.176
, pp. 40-50
-
-
Kimura, A.1
Ishida, Y.2
Wada, T.3
-
17
-
-
0031052252
-
Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo
-
Eitner F, Westerhuis R, Burg M, et al,. Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo. Kidney Int. 1997; 51: 69-78. (Pubitemid 27064523)
-
(1997)
Kidney International
, vol.51
, Issue.1
, pp. 69-78
-
-
Eitner, F.1
Westerhuis, R.2
Burg, M.3
Weinhold, B.4
Grone, H.-J.5
Ostendorf, T.6
Ruther, U.7
Koch, K.-M.8
Rees, A.J.9
Floege, J.10
-
18
-
-
77957661299
-
Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
-
Matthews VB, Allen TL, Risis S, et al,. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 2010; 53: 2431-41.
-
(2010)
Diabetologia
, vol.53
, pp. 2431-2441
-
-
Matthews, V.B.1
Allen, T.L.2
Risis, S.3
-
19
-
-
77956335194
-
Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action
-
Wunderlich FT, Strohle P, Konner AC, et al,. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab. 2010; 12: 237-49.
-
(2010)
Cell Metab.
, vol.12
, pp. 237-249
-
-
Wunderlich, F.T.1
Strohle, P.2
Konner, A.C.3
-
20
-
-
34948882675
-
Glycemic control and critical illness: Is the kidney involved?
-
DOI 10.1681/ASN.2007010109
-
Mehta RL,. Glycemic control and critical illness: Is the kidney involved? J. Am. Soc. Nephrol. 2007; 18: 2623-7. (Pubitemid 47531187)
-
(2007)
Journal of the American Society of Nephrology
, vol.18
, Issue.10
, pp. 2623-2627
-
-
Mehta, R.L.1
-
21
-
-
52649114296
-
Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs
-
Tikellis C, Thomas MC, Harcourt BE, et al,. Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am. J. Physiol. Endocrinol. Metab. 2008; 295: E323-30.
-
(2008)
Am. J. Physiol. Endocrinol. Metab.
, vol.295
-
-
Tikellis, C.1
Thomas, M.C.2
Harcourt, B.E.3
-
22
-
-
0141483457
-
The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes
-
Forbes JM, Thallas V, Thomas MC, et al,. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J. 2003; 17: 1762-4.
-
(2003)
FASEB J.
, vol.17
, pp. 1762-1764
-
-
Forbes, J.M.1
Thallas, V.2
Thomas, M.C.3
-
23
-
-
33645357545
-
Nondiabetic consequences of obesity on kidney
-
Srivastava T,. Nondiabetic consequences of obesity on kidney. Pediatr. Nephrol. 2006; 21: 463-70.
-
(2006)
Pediatr. Nephrol.
, vol.21
, pp. 463-470
-
-
Srivastava, T.1
-
24
-
-
0029120410
-
Combined renal effects of overweight and hypertension
-
Ribstein J, du Cailar G, Mimran A,. Combined renal effects of overweight and hypertension. Hypertension 1995; 26: 610-15.
-
(1995)
Hypertension
, vol.26
, pp. 610-615
-
-
Ribstein, J.1
Du Cailar, G.2
Mimran, A.3
-
25
-
-
0038341934
-
Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice
-
DOI 10.1189/jlb.0802397
-
Lin ZQ, Kondo T, Ishida Y, Takayasu T, Mukaida N,. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J. Leukoc. Biol. 2003; 73: 713-21. (Pubitemid 38040449)
-
(2003)
Journal of Leukocyte Biology
, vol.73
, Issue.6
, pp. 713-721
-
-
Lin, Z.-Q.1
Kondo, T.2
Ishida, Y.3
Takayasu, T.4
Mukaida, N.5
-
26
-
-
72849142816
-
An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice
-
Tieu BC, Lee C, Sun H, et al,. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J. Clin. Invest. 2009; 119: 3637-51.
-
(2009)
J. Clin. Invest.
, vol.119
, pp. 3637-3651
-
-
Tieu, B.C.1
Lee, C.2
Sun, H.3
-
27
-
-
33646701639
-
Interleukin-6 in rheumatoid arthritis
-
DOI 10.1097/01.bor.0000218949.19860.d1, PII 0000228120060500000011
-
Nishimoto N,. Interleukin-6 in rheumatoid arthritis. Curr. Opin. Rheumatol. 2006; 18: 277-81. (Pubitemid 43740380)
-
(2006)
Current Opinion in Rheumatology
, vol.18
, Issue.3
, pp. 277-281
-
-
Nishimoto, N.1
-
28
-
-
0142250392
-
Targeted Anti-Interleukin-6 Monoclonal Antibody Therapy for Cancer: A Review of the Rationale and Clinical Evidence
-
Trikha M, Corringham R, Klein B, Rossi JF,. Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: A review of the rationale and clinical evidence. Clin. Cancer Res. 2003; 9: 4653-65. (Pubitemid 37323267)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.13
, pp. 4653-4665
-
-
Trikha, M.1
Corringham, R.2
Klein, B.3
Rossi, J.-F.4
-
29
-
-
0036152683
-
Interleukin-6-deficient mice develop mature-onset obesity
-
DOI 10.1038/nm0102-75
-
Wallenius V, Wallenius K, Ahren B, et al,. Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 2002; 8: 75-9. (Pubitemid 34101732)
-
(2002)
Nature Medicine
, vol.8
, Issue.1
, pp. 75-79
-
-
Wallenius, V.1
Wallenius, K.2
Ahren, B.3
Rudling, M.4
Carlsten, H.5
Dickson, S.L.6
Ohlsson, C.7
Jansson, J.-O.8
-
30
-
-
69449087197
-
Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice
-
Tomiyama-Hanayama M, Rakugi H, Kohara M, et al,. Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice. Am. J. Physiol. Renal Physiol. 2009; 297: F679-84.
-
(2009)
Am. J. Physiol. Renal Physiol.
, vol.297
-
-
Tomiyama-Hanayama, M.1
Rakugi, H.2
Kohara, M.3
-
31
-
-
33645212094
-
All-trans-retinoic acid inhibits the development of mesangial proliferative glomerulonephritis in interleukin-6 transgenic mice
-
Shima Y, Iwano M, Yoshizaki K, Tanaka T, Kawase I, Nishimoto N,. All-trans-retinoic acid inhibits the development of mesangial proliferative glomerulonephritis in interleukin-6 transgenic mice. Nephron Exp. Nephrol. 2005; 100: e54-62.
-
(2005)
Nephron Exp. Nephrol.
, vol.100
-
-
Shima, Y.1
Iwano, M.2
Yoshizaki, K.3
Tanaka, T.4
Kawase, I.5
Nishimoto, N.6
-
32
-
-
0028328436
-
Impaired immune and acute-phase responses in interleukin-6-deficient mice
-
DOI 10.1038/368339a0
-
Kopf M, Baumann H, Freer G, et al,. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994; 368: 339-42. (Pubitemid 24104268)
-
(1994)
Nature
, vol.368
, Issue.6469
, pp. 339-342
-
-
Kopf, M.1
Baumann, H.2
Freer, G.3
Freudenberg, M.4
Lamers, M.5
Kishimoto, T.6
Zinkernagel, R.7
Bluethmann, H.8
Kohler, G.9
|